Antisense Oligonucleotides: A Unique Treatment Approach

被引:10
|
作者
Krishnan, Abhinaya V. [1 ]
Mishra, Devendra [1 ]
机构
[1] Univ Delhi, Maulana Azad Med Coll, Dept Pediat, Delhi 110002, India
关键词
Duchenne muscular dystrophy; Eteplirsen; Nusinersen; Spinal muscular atrophy; Treatment; SHAM CONTROL; NUSINERSEN; THERAPIES; SAFETY; TRIAL;
D O I
10.1007/s13312-020-1736-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Synthetic Antisense oligonucleotides (ASOs) are novel and efficient laboratory tools to regulate the expression of specific genes, and have only recently come into clinical use. These are synthetic single-stranded DNA analogs, whose sequence is complementary to a target nucleotide and alter protein synthesis by several mechanisms. We herein provide a primer on the topic for pediatricians, as this group of drugs is likely to see many more drugs for previously incurable diseases.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 50 条
  • [1] Antisense Oligonucleotides: A Unique Treatment Approach
    Abhinaya V. Krishnan
    Devendra Mishra
    Indian Pediatrics, 2020, 57 : 165 - 171
  • [2] Multitargeted approach using antisense oligonucleotides for the treatment of asthma
    Allakhverdi, Z.
    Allam, M.
    Guimond, A.
    Ferrari, N.
    Zemzoumi, K.
    Seguin, R.
    Paquet, L.
    Renzi, P. M.
    OLIGONUCLEOTIDE THERAPEUTICS, 2006, 1082 : 62 - 73
  • [3] Antisense oligonucleotides in the treatment of cancer
    Dorr, FA
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1999, 9 (04): : 391 - 396
  • [4] Antisense oligonucleotides for the treatment of dyslipidaemia
    Visser, Maartje E.
    Witztum, Joseph L.
    Stroes, Erik S. G.
    Kastelein, John J. P.
    EUROPEAN HEART JOURNAL, 2012, 33 (12) : 1451 - 1458
  • [5] Antisense Oligonucleotides for the Treatment of Dyslipidemia
    Gouni-Berthold, I.
    Berthold, H. K.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (09) : 950 - 960
  • [6] Antisense oligonucleotides: A novel approach for the treatment of androgenic skin disorders.
    Hartwell, J
    Saunders, J
    Bhan, A
    Bhan, P
    Hoke, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 691 - 691
  • [7] Antisense oligonucleotides: a new therapeutic approach
    Temsamani, J
    Guinot, P
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 1997, 26 : 65 - 71
  • [8] Antisense oligonucleotides in the treatment of bladder cancer
    Glackin, AJ
    Gray, SB
    Johnston, SR
    Duggan, BJ
    Williamson, KE
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (01) : 67 - 77
  • [9] Antisense oligonucleotides strategy in the treatment of hypertension
    Kagiyama, S
    Kagiyama, T
    Phillips, MI
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2001, 3 (03) : 258 - 264
  • [10] Antisense oligonucleotides for the treatment of neurodegenerative diseases
    Zhao, Hien T.
    Kordasiewicz, Holly
    Norris, Dan
    Smith, Anne
    Lane, Roger
    Bennett, C. Frank
    Swayze, Eric
    PRION, 2019, 13 : 94 - 95